Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:07 pm Unchanged |
2024-12-31 | 13G | Rekor Systems, Inc. REKR |
Armistice Capital, LLC | 2,850,000 2.950% |
0 (Unchanged) |
Filing History |
| 2025-02-14 5:07 pm Sale |
2024-12-31 | 13G | Avinger, Inc. AVGR |
Armistice Capital, LLC | 278,769 4.990% |
-25,242 (-8.30%) |
Filing History |
| 2025-02-14 5:06 pm Unchanged |
2024-12-31 | 13G | Protagenic Therapeutics, Inc. PTIX |
Armistice Capital, LLC | 240,000 3.410% |
0 (Unchanged) |
Filing History |
| 2025-02-14 5:06 pm Purchase |
2024-12-31 | 13G | Neuphoria Therapeutics Inc. NEUP |
Armistice Capital, LLC | 1,033,796 4.990% |
1,033,796 (New Position) |
Filing History |
| 2025-02-14 5:05 pm Sale |
2024-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
Armistice Capital, LLC | 6,400,000 4.470% |
-1,800,000 (-21.95%) |
Filing History |
| 2025-02-14 5:04 pm Purchase |
2024-12-31 | 13G | XORTX Therapeutics Inc. XRTX |
Armistice Capital, LLC | 346,807 9.990% |
177,017 (+104.26%) |
Filing History |
| 2025-02-14 5:01 pm Purchase |
2024-12-31 | 13G | Wearable Devices Ltd. WLDS |
Armistice Capital, LLC | 91,589 9.990% |
91,589 (New Position) |
Filing History |
| 2025-02-14 5:01 pm Purchase |
2024-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
Armistice Capital, LLC | 9,134,817 9.990% |
9,134,817 (New Position) |
Filing History |
| 2025-02-14 5:01 pm Sale |
2024-12-31 | 13G | Avenue Therapeutics, Inc. ATXI |
Armistice Capital, LLC | 100,400 4.990% |
-14,600 (-12.70%) |
Filing History |
| 2025-02-14 4:58 pm Sale |
2024-12-31 | 13G | Assembly Biosciences, Inc. ASMB |
Armistice Capital, LLC | 316,084 4.990% |
-37,916 (-10.71%) |
Filing History |
| 2025-02-14 4:57 pm Sale |
2024-12-31 | 13G | Aptose Biosciences Inc. APTO |
Armistice Capital, LLC | 34,176 4.990% |
-30,998 (-47.56%) |
Filing History |
| 2025-02-14 4:57 pm Purchase |
2024-12-31 | 13G | Kartoon Studios Inc. TOON |
Armistice Capital, LLC | 4,607,156 9.990% |
4,607,156 (New Position) |
Filing History |
| 2025-02-14 4:56 pm Purchase |
2024-12-31 | 13G | Senti Biosciences, Inc. SNTI |
Armistice Capital, LLC | 536,010 9.990% |
536,010 (New Position) |
Filing History |
| 2025-02-14 4:56 pm Sale |
2024-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
Armistice Capital, LLC | 188,438 4.990% |
-131,318 (-41.07%) |
Filing History |
| 2025-02-14 4:56 pm Purchase |
2024-12-31 | 13G | Stryve Foods, Inc. SNAX |
Armistice Capital, LLC | 445,245 9.990% |
445,245 (New Position) |
Filing History |
| 2025-02-14 4:55 pm Sale |
2024-12-31 | 13G | AIM ImmunoTech Inc. AIM |
Armistice Capital, LLC | 3,349,740 4.990% |
-980,260 (-22.64%) |
Filing History |
| 2025-02-14 4:55 pm Purchase |
2024-12-31 | 13G | Shuttle Pharmaceuticals Holdings, Inc. SHPH |
Armistice Capital, LLC | 306,057 7.510% |
306,057 (New Position) |
Filing History |
| 2025-02-14 4:54 pm Purchase |
2024-12-31 | 13G | Quoin Pharmaceuticals, Ltd. QNRX |
Armistice Capital, LLC | 46,716 9.990% |
46,716 (New Position) |
Filing History |
| 2025-02-14 4:50 pm Sale |
2024-12-31 | 13G | Accelerate Diagnostics, Inc. AXDX |
Armistice Capital, LLC | 2,078,000 8.250% |
-322,000 (-13.42%) |
Filing History |
| 2025-02-14 4:49 pm Purchase |
2024-12-31 | 13G | Palatin Technologies, Inc. PTN |
Armistice Capital, LLC | 1,992,826 8.500% |
1,272,497 (+176.65%) |
Filing History |